These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 15091230)

  • 41. Assessing cisplatin-induced ototoxicity and otoprotection in whole organ culture of the mouse inner ear in simulated microgravity.
    Tropitzsch A; Arnold H; Bassiouni M; Müller A; Eckhard A; Müller M; Löwenheim H
    Toxicol Lett; 2014 Jun; 227(3):203-12. PubMed ID: 24709139
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Aminoglycoside- and cisplatin-ototoxicity: from basic science to clinics].
    Lautermann J; Dehne N; Schacht J; Jahnke K
    Laryngorhinootologie; 2004 May; 83(5):317-23. PubMed ID: 15143449
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Characterization of atypical cells in the juvenile rat organ of corti after aminoglycoside ototoxicity.
    Daudet N; Vago P; Ripoll C; Humbert G; Pujol R; Lenoir M
    J Comp Neurol; 1998 Nov; 401(2):145-62. PubMed ID: 9822146
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Hydrogen protects auditory hair cells from cisplatin-induced free radicals.
    Kikkawa YS; Nakagawa T; Taniguchi M; Ito J
    Neurosci Lett; 2014 Sep; 579():125-9. PubMed ID: 25064701
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Cisplatin ototoxicity and otoprotection with sodium salicylate.
    Hyppolito MA; de Oliveira JA; Rossato M
    Eur Arch Otorhinolaryngol; 2006 Sep; 263(9):798-803. PubMed ID: 16758221
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Diameter of the cochlear nerve in endolymphatic hydrops: implications for the etiology of hearing loss in Ménière's disease.
    Megerian CA
    Laryngoscope; 2005 Sep; 115(9):1525-35. PubMed ID: 16148690
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Biopolymer-released dexamethasone prevents tumor necrosis factor alpha-induced loss of auditory hair cells in vitro: implications toward the development of a drug-eluting cochlear implant electrode array.
    Dinh C; Hoang K; Haake S; Chen S; Angeli S; Nong E; Eshraghi AA; Balkany TJ; Van De Water TR
    Otol Neurotol; 2008 Oct; 29(7):1012-9. PubMed ID: 18818545
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Evaluation of the effect of acetyl L-carnitine on experimental cisplatin ototoxicity and neurotoxicity.
    Gunes D; Kirkim G; Kolatan E; Guneri EA; Ozogul C; Altun Z; Serbetcioglu B; Yilmaz O; Aktas S; Mutafoglu K; Tufekci O; Erbayraktar Z; Olgun N
    Chemotherapy; 2011; 57(3):186-94. PubMed ID: 21525749
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cell death after co-administration of cisplatin and ethacrynic acid.
    Ding D; Jiang H; Wang P; Salvi R
    Hear Res; 2007 Apr; 226(1-2):129-39. PubMed ID: 16978814
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Comparative studies of the ototoxicity of cisplatin and carboplatin].
    Delb W; Feilen S; Koch A; Federspil P
    Laryngorhinootologie; 1993 Jan; 72(1):24-7. PubMed ID: 8439352
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prevention of noise- and drug-induced hearing loss with D-methionine.
    Campbell KC; Meech RP; Klemens JJ; Gerberi MT; Dyrstad SS; Larsen DL; Mitchell DL; El-Azizi M; Verhulst SJ; Hughes LF
    Hear Res; 2007 Apr; 226(1-2):92-103. PubMed ID: 17224251
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Augmented ototoxic effect of cisplatin in heterozygotes of the German waltzing guinea pig.
    Skjonsberg A; Bucinskaite V; Laurell G; Ulfendahl M
    Audiol Neurootol; 2008; 13(2):97-104. PubMed ID: 18057873
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Osteopontin does not mitigate cisplatin ototoxicity or nephrotoxicity in adult mice.
    Schmitt NC; Rubel EW
    Otolaryngol Head Neck Surg; 2013 Oct; 149(4):614-20. PubMed ID: 23884286
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A review of cis-platinum ototoxicity.
    Moroso MJ; Blair RL
    J Otolaryngol; 1983 Dec; 12(6):365-9. PubMed ID: 6686617
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Smad5 haploinsufficiency leads to hair cell and hearing loss.
    Yang SM; Guo WW; Hu YY; Sun YX; Hou ZH; Sun JH; Wang X; He DZ; Zhai SQ; Young WY; Han DY; Yang X
    Dev Neurobiol; 2009 Feb 1-15; 69(2-3):153-61. PubMed ID: 19067324
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hexachlorobenzene, a dioxin-like compound, disrupts auditory function in rat.
    Hadjab S; Maurel D; Cazals Y; Siaud P
    Hear Res; 2004 May; 191(1-2):125-34. PubMed ID: 15109712
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Left-right asymmetry in hearing loss following cisplatin therapy in children--the left ear is slightly but significantly more affected.
    Schmidt CM; Knief A; Lagosch AK; Deuster D; am Zehnhoff-Dinnesen A
    Ear Hear; 2008 Dec; 29(6):830-7. PubMed ID: 18772725
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Electrophysiological evaluation of the hearing function following cisplatin administration].
    Bogomol'skiĭ MR; D'iakonova IN; Rakhmanova IV; Sapozhnikov IaM; Stakhovskaia OR; Tikhomirov AM
    Vestn Otorinolaringol; 2010; (3):24-6. PubMed ID: 20559247
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Ototoxicity in a randomized phase III trial of intra-arterial compared with intravenous cisplatin chemoradiation in patients with locally advanced head and neck cancer.
    Zuur CL; Simis YJ; Lansdaal PE; Hart AA; Schornagel JH; Dreschler WA; Rasch CR; Balm AJ
    J Clin Oncol; 2007 Aug; 25(24):3759-65. PubMed ID: 17704425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Correlation of increased activities of Na+, K+-ATPase and Ca2+-ATPase with the reversal of cisplatin ototoxicity induced by D-methionine in guinea pigs.
    Cheng PW; Liu SH; Hsu CJ; Lin-Shiau SY
    Hear Res; 2005 Jul; 205(1-2):102-9. PubMed ID: 15953519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.